GH1 and neoplasm: In some MEN1 patients, poorly differentiated PIT1-lineage tumours, previously known as “silent subtype 3 adenoma”, have been observed [87], with a variable combination of GH, prolactin, α-subunit and thyroid-stimulating hormone.